Page last updated: 2024-10-29

ketanserin and Causalgia

ketanserin has been researched along with Causalgia in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Causalgia: A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, JA1
Beswick, T1
Dickson, G1

Other Studies

1 other study available for ketanserin and Causalgia

ArticleYear
Ketanserin and guanethidine in the treatment of causalgia.
    Anesthesia and analgesia, 1987, Volume: 66, Issue:6

    Topics: Administration, Oral; Causalgia; Female; Guanethidine; Humans; Injections, Intravenous; Ketanserin;

1987